Please assess the completion status of the following clinical trial:

Trial Title: AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ischemic stroke diagnosis by CT/MRI scan~* Yin pattern of Traditional Chinese Medicine Theory~* 40-85 years old~* Total anterior circulation infarcts (TACI), partial anterior territory cerebral infarction (PACI), lacunar anterior circulation infarcts (LACI) type under Oxfordshire Community Stroke Project (OCSP) standard~* NIHSS \>=4;~* Glasgow coma scale (GCS) \>=7;~* Modified Rankin Scale less than 2 degrees before onset of this stroke~* Informed consent signed by patient or his/her family~Exclusion Criteria:~* Hemorrhagic stroke;~* Coma, GCS\<=7;~* Cerebral hernia;~* Serious heart, liver, lung, kidney functional failure;~* Gastrointestinal (GI) bleeding;~* Thrombolysis drugs or surgery was administrated to the patient;~* Not cooperative with physician;~* Psychological disorder;~* Already taken part in other clinical drug trial within the past 3 months

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Chinese herbal medicine (Type: EXPERIMENTAL): None
- placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).